Over the past decade, a myriad of novel therapeutic options for neurodegenerative diseases have emerged, fundamentally altering the landscape and future management of complex neurological disorders. Notably, the potential of monoclonal antibodies as disease-modifying agents in Alzheimer's disease exemplifies this transformative shift. While the full impact of these new therapeutic entities is yet to be determined, it is evident that a diverse array of modalities will be required to effectively address the entire spectrum of neurodegenerative diseases. Consequently, there is a pressing need to optimize new chemical entities, develop innovative delivery strategies, and identify differential molecular targets through multidisciplinary approaches.
This Research Topic aims to highlight both fundamental and clinical research that will underpin the next generation of therapies for neurodegenerative diseases. The presented research will encompass state-of-the-art developments in biology, chemistry, drug delivery, and clinical breakthroughs, embodying a transdisciplinary approach. It will provide critical insights into current barriers, introduce innovative methods, and outline the future trajectory of neurological medicine in the 21st century.
To achieve a comprehensive overview of current research, this collection will prioritize Original Research articles, including those that describe new Methods, Case Reports, or Clinical Trials, comprising 50% of the accepted submissions. Additionally, we welcome submissions of various article types such as General Commentaries, Mini Reviews, Opinions, Perspectives, and Reviews. This diverse array of contributions will ensure a rich and holistic exploration of the advances and future directions in the treatment of neurodegenerative diseases.
Keywords:
drug discovery, neurodegenerative disease, novel therapeutics, neurological disorders
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Over the past decade, a myriad of novel therapeutic options for neurodegenerative diseases have emerged, fundamentally altering the landscape and future management of complex neurological disorders. Notably, the potential of monoclonal antibodies as disease-modifying agents in Alzheimer's disease exemplifies this transformative shift. While the full impact of these new therapeutic entities is yet to be determined, it is evident that a diverse array of modalities will be required to effectively address the entire spectrum of neurodegenerative diseases. Consequently, there is a pressing need to optimize new chemical entities, develop innovative delivery strategies, and identify differential molecular targets through multidisciplinary approaches.
This Research Topic aims to highlight both fundamental and clinical research that will underpin the next generation of therapies for neurodegenerative diseases. The presented research will encompass state-of-the-art developments in biology, chemistry, drug delivery, and clinical breakthroughs, embodying a transdisciplinary approach. It will provide critical insights into current barriers, introduce innovative methods, and outline the future trajectory of neurological medicine in the 21st century.
To achieve a comprehensive overview of current research, this collection will prioritize Original Research articles, including those that describe new Methods, Case Reports, or Clinical Trials, comprising 50% of the accepted submissions. Additionally, we welcome submissions of various article types such as General Commentaries, Mini Reviews, Opinions, Perspectives, and Reviews. This diverse array of contributions will ensure a rich and holistic exploration of the advances and future directions in the treatment of neurodegenerative diseases.
Keywords:
drug discovery, neurodegenerative disease, novel therapeutics, neurological disorders
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.